These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6653052)

  • 21. Aminoglycoside nephrotoxicity: recent developments.
    Walker R
    N Z Med J; 1994 Feb; 107(972):54-5. PubMed ID: 8115070
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aminoglycoside nephrotoxicity. III. Changes in subcellular elements].
    Fillastre JP; Morin JP; Bendirdjian JP; Viotte G; Godin M
    Nephrologie; 1980; 1(3):145-52. PubMed ID: 7027065
    [No Abstract]   [Full Text] [Related]  

  • 23. Aminoglycoside antibiotics: unsafe at any dose?
    MacDougall ML
    J Lab Clin Med; 1988 Dec; 112(6):669-70. PubMed ID: 3193022
    [No Abstract]   [Full Text] [Related]  

  • 24. Nephrotoxicity of cephalothin-aminoglycoside interactions.
    Barriere SL
    Arch Intern Med; 1982 Sep; 142(9):1754. PubMed ID: 7114997
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vancomycin and teicoplanin: differential aspects].
    Cobo J
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):600-10. PubMed ID: 8808477
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetes: a risk factor in aminoglycoside nephrotoxicity.
    Rush DS; DiPiro JT; Record KT; Bivins BA
    Curr Surg; 1982; 39(4):244-7. PubMed ID: 7116917
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
    Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aminoglycoside nephrotoxicity. I. Clinical aspects, morphology and tissue pharmacokinetics].
    Fabre J
    Nephrologie; 1980; 1(1):37-43. PubMed ID: 7029331
    [No Abstract]   [Full Text] [Related]  

  • 29. [Early urinary markers of aminoglycoside nephrotoxicity (author's transl)].
    Nicot G; Charmes JP; Valette JP; Merle L; Dany F; Brosset P; Lachatre G
    Therapie; 1980; 35(3):369-74. PubMed ID: 7423429
    [No Abstract]   [Full Text] [Related]  

  • 30. Predicting aminoglycoside serum levels.
    Barriere SL
    Am J Hosp Pharm; 1979 Jan; 36(1):28. PubMed ID: 758781
    [No Abstract]   [Full Text] [Related]  

  • 31. What to watch for when you give aminoglycosides.
    White SJ; Williamson K
    RN; 1979 Sep; 42(9):73-5. PubMed ID: 257729
    [No Abstract]   [Full Text] [Related]  

  • 32. Do cephalosporins potentiate or antagonize aminoglycoside nephrotoxicity?
    Marsh FP
    J Antimicrob Chemother; 1978 Mar; 4(2):103-6. PubMed ID: 649529
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of antibiotic-induced nephrotoxicity.
    Seale TW; Rennert OM
    Ann Clin Lab Sci; 1982; 12(1):1-10. PubMed ID: 6279013
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nephrotoxicity of aminoglycosides: introduction, risk factors (I)].
    Arellano Abia F
    Med Clin (Barc); 1989 Sep; 93(7):269-73. PubMed ID: 2682062
    [No Abstract]   [Full Text] [Related]  

  • 35. [Aminoglycosides and polymyxins].
    Molina J; Cordero E; Palomino J; Pachón J
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Back to the future: using aminoglycosides again and how to dose them optimally.
    Drusano GL; Ambrose PG; Bhavnani SM; Bertino JS; Nafziger AN; Louie A
    Clin Infect Dis; 2007 Sep; 45(6):753-60. PubMed ID: 17712761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
    Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA
    J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single daily dosing of aminoglycosides.
    Preston SL; Briceland LL
    Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interaction of digoxin with cephradine (Sefril), tetracycline (Tetracyclinum), gentamicin (Gentamycin) and vancomycin (Vancocin)].
    Halawa B
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1717-20. PubMed ID: 6522324
    [No Abstract]   [Full Text] [Related]  

  • 40. [Aminoglycosides: once a day?].
    Fantin B
    Rev Prat; 1998 Feb; 48(4):353-5. PubMed ID: 9781087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.